🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 19 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 14/02/2003 | 14,11 | 14,86 | 13,92 | 14,45 | +3,49% | 6,63% | 60.914 |
| 13/02/2003 | 14,93 | 14,93 | 13,81 | 13,96 | -5,57% | 7,52% | 40.796 |
| 12/02/2003 | 14,49 | 15,23 | 14,15 | 14,78 | +1,54% | 7,49% | 82.047 |
| 11/02/2003 | 14,60 | 15,16 | 14,19 | 14,56 | -0,26% | 6,67% | 71.280 |
| 10/02/2003 | 14,90 | 14,93 | 13,89 | 14,60 | -1,76% | 7,03% | 80.203 |
| 07/02/2003 | 15,65 | 15,91 | 14,86 | 14,86 | -5,02% | 6,70% | 78.547 |
| 06/02/2003 | 15,98 | 16,09 | 15,31 | 15,65 | -2,34% | 4,92% | 152.472 |
| 05/02/2003 | 16,43 | 16,77 | 15,65 | 16,02 | -2,06% | 6,83% | 177.425 |
| 04/02/2003 | 17,18 | 17,18 | 16,21 | 16,36 | -4,79% | 5,66% | 232.916 |
| 03/02/2003 | 17,48 | 17,89 | 17,03 | 17,18 | -1,50% | 4,93% | 138.392 |
| 31/01/2003 | 17,85 | 17,97 | 17,29 | 17,44 | -1,06% | 3,77% | 332.676 |
| 30/01/2003 | 18,27 | 18,34 | 17,59 | 17,63 | -3,09% | 4,10% | 60.540 |
| 29/01/2003 | 18,00 | 18,30 | 17,44 | 18,19 | +1,04% | 4,78% | 129.843 |
| 28/01/2003 | 18,57 | 18,64 | 17,82 | 18,00 | -3,41% | 4,44% | 91.024 |
| 27/01/2003 | 18,86 | 19,24 | 18,12 | 18,64 | -0,60% | 5,95% | 101.684 |
| 24/01/2003 | 19,58 | 19,91 | 18,75 | 18,75 | -4,02% | 5,93% | 82.822 |
| 23/01/2003 | 19,09 | 19,80 | 18,90 | 19,54 | +1,16% | 4,71% | 106.306 |
| 22/01/2003 | 19,61 | 19,61 | 19,05 | 19,31 | -1,34% | 2,86% | 110.794 |
| 21/01/2003 | 19,65 | 19,73 | 19,16 | 19,58 | -0,19% | 2,86% | 57.815 |
| 17/01/2003 | 19,84 | 19,99 | 19,39 | 19,61 | -2,24% | 3,02% | 50.869 |
| 16/01/2003 | 20,62 | 21,34 | 19,84 | 20,06 | -2,37% | 7,26% | 83.596 |
| 15/01/2003 | 21,34 | 21,90 | 20,29 | 20,55 | -5,67% | 7,54% | 61.048 |
| 14/01/2003 | 21,30 | 21,97 | 21,15 | 21,78 | +2,28% | 3,87% | 65.322 |
| 13/01/2003 | 20,81 | 21,48 | 20,29 | 21,30 | +2,52% | 5,76% | 60.941 |
| 10/01/2003 | 19,91 | 20,77 | 19,58 | 20,77 | +4,32% | 6,02% | 61.528 |
| 09/01/2003 | 19,73 | 20,40 | 19,69 | 19,91 | +0,95% | 3,61% | 53.220 |
| 08/01/2003 | 19,80 | 20,59 | 19,65 | 19,73 | -0,38% | 4,73% | 90.997 |
| 07/01/2003 | 20,66 | 20,77 | 19,73 | 19,80 | -3,64% | 5,07% | 150.789 |
| 06/01/2003 | 20,21 | 20,85 | 20,06 | 20,55 | +2,04% | 3,89% | 115.550 |
| 03/01/2003 | 20,66 | 21,04 | 20,14 | 20,14 | -1,65% | 4,35% | 289.288 |